FR2229416A1 - Cyclocytidine improved freeze-dried prepns. - by freeze-drying solns. of cyclocytidine and a saccharide, polyvinylpyrrolidone etc. - Google Patents

Cyclocytidine improved freeze-dried prepns. - by freeze-drying solns. of cyclocytidine and a saccharide, polyvinylpyrrolidone etc.

Info

Publication number
FR2229416A1
FR2229416A1 FR7417294A FR7417294A FR2229416A1 FR 2229416 A1 FR2229416 A1 FR 2229416A1 FR 7417294 A FR7417294 A FR 7417294A FR 7417294 A FR7417294 A FR 7417294A FR 2229416 A1 FR2229416 A1 FR 2229416A1
Authority
FR
France
Prior art keywords
freeze
cyclocytidine
saccharide
drying
dried
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7417294A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kohjin Co
Original Assignee
Kohjin Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kohjin Co filed Critical Kohjin Co
Publication of FR2229416A1 publication Critical patent/FR2229416A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FR7417294A 1973-05-17 1974-05-17 Cyclocytidine improved freeze-dried prepns. - by freeze-drying solns. of cyclocytidine and a saccharide, polyvinylpyrrolidone etc. Withdrawn FR2229416A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5414573A JPS5637967B2 (OSRAM) 1973-05-17 1973-05-17

Publications (1)

Publication Number Publication Date
FR2229416A1 true FR2229416A1 (en) 1974-12-13

Family

ID=12962379

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7417294A Withdrawn FR2229416A1 (en) 1973-05-17 1974-05-17 Cyclocytidine improved freeze-dried prepns. - by freeze-drying solns. of cyclocytidine and a saccharide, polyvinylpyrrolidone etc.

Country Status (4)

Country Link
JP (1) JPS5637967B2 (OSRAM)
DE (1) DE2423811A1 (OSRAM)
ES (1) ES426414A1 (OSRAM)
FR (1) FR2229416A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571962A1 (fr) * 1984-10-24 1986-04-25 Sandoz Sa Nouvelles formulations galeniques a base de bromocriptine.

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139613A (en) * 1975-05-24 1976-12-02 Nippon Shinyaku Co Ltd An absorbable non-crystalline sterol glycoside monopalmitate ester and a method for preparing its pharmaceutical
DE2658406C2 (de) * 1975-12-31 1984-04-26 Asahi Kasei Kogyo K.K., Osaka Verfahren zur Herstellung wasserlöslicher Arzneimittelzubereitungen, enthaltend N↑4↑-Acylcytosin-arabinosid
ID21635A (id) * 1996-12-20 1999-07-08 Astra Pharma Prod Komposisi farmasi untuk pengeringan beku
KR0181252B1 (ko) * 1996-12-31 1999-03-20 박원훈 에멀젼 방법에 의한 다공성 매트릭스형 서방성 제제의 제조방법
US6417167B1 (en) 1997-02-05 2002-07-09 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing shingoglycolipid and process for preparing them
DE69824301T2 (de) * 1997-02-05 2005-06-02 Kirin Beer K.K. Glycosphingolipide enthaltende gefriergetrocknete zusammensetzung
SE9702680D0 (sv) * 1997-07-11 1997-07-11 Astra Pharma Prod New formulation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571962A1 (fr) * 1984-10-24 1986-04-25 Sandoz Sa Nouvelles formulations galeniques a base de bromocriptine.

Also Published As

Publication number Publication date
ES426414A1 (es) 1976-07-01
JPS505523A (OSRAM) 1975-01-21
DE2423811A1 (de) 1974-12-05
JPS5637967B2 (OSRAM) 1981-09-03

Similar Documents

Publication Publication Date Title
IE38897L (en) Non-ionic cellulose ethers.
IE40663L (en) Oxytetracycline solutions
GB1420788A (en) Injectable preparations
GB1340516A (en) Ophthalmic solution
GB1044649A (en) Improvements in or relating to the preservation of blood
FR2176794A1 (en) Machine dish washing - using clear rinsing agent contg ethylene and propylene oxide adducts of guerbet alcohols
GB1164569A (en) Improvements in or relating to Antilipaemic Sulphated Polysaccharides
GB1358790A (en) Method for the production of maltose of high purifity
GB1001205A (en) Cellulose derivative solution for shaping and preparation thereof
GB1270049A (en) New pharmaceutical product
ES427653A1 (es) Procedimiento para la preparacion de nuevos acidos 3-hidro- xiacilaminometil-5-acilamino-2, 4, 6-triyodo-benzoicos.
ES426414A1 (es) Metodo para producir una preparacion de ciclocitidina seca-da por congelacion.
FR2285855A1 (fr) Composition therapeutique lyophilisee a base de sel de cyclocytidine et son procede de preparation
US2669563A (en) Bismuth salt of penicillin
ES384039A1 (es) Procedimiento para la preparacion de glicolfosfatidos.
US2289050A (en) Solution of difficultly water soluble medicinal agents
GB1373698A (en) Stabilized microbial rennet and process for preparing same
GB1513556A (en) Manufacture of hydroxyl-containing polymers
GB1173558A (en) A Process for Preparing Pure Ribonuclease.
JPS539312A (en) Preparation of light-stable mecobalamin or cobamamide parenteral injections
KIM Experimental Studies on the Effects of Adrenocorticosteroid in the Rabbits Given Diphtheria Toxin
GB770075A (en) Improvements in or relating to preparation of a fibrinogen product and stable solutions thereof
GB1360032A (en) 2-thio-5-azocytosine and its nucleosides
IE34987B1 (en) Denture adhesive
GB1144439A (en) New sugar coating solution

Legal Events

Date Code Title Description
ST Notification of lapse